Jonathan Sporn

Gründer bei Gilgamesh Pharmaceuticals, Inc.

Health Services

Health Technology

Profil

Jonathan Sporn is the founder of Perception Neuroscience, Inc. and Gilgamesh Pharmaceuticals, Inc. At Perception Neuroscience, he holds no specific title.
At Gilgamesh Pharmaceuticals, he held the titles of President, Chief Executive Officer, and Director, but is no longer active in those roles.

Aktive Positionen von Jonathan Sporn

Unternehmen	Position	Beginn
Gilgamesh Pharmaceuticals, Inc. Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY.	Gründer	-

Alle aktiven Positionen von Jonathan Sporn

Ehemalige bekannte Positionen von Jonathan Sporn

Unternehmen	Position	Ende
Perception Neuroscience, Inc. Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.	Gründer	-

Sehen Sie sich die Erfahrung von Jonathan Sporn im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jonathan Sporn im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Perception Neuroscience, Inc. Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.	Health Services
Gilgamesh Pharmaceuticals, Inc. Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY.	Health Technology